Hemorrhage causes significant morbidity and mortality in people aged <65 years. A lyophilized platelet-derived...
Read More
Thromboelastography was first described more than half a century ago by Hellmut Hartert. Today...
Emicizumab represents a therapeutic innovation not only for haemophiliacs A with inhibitor but also...
Current standard therapy for severe hemophilia A is regular infusions of either plasma-derived or...
Patients affected by severe hemophilia A and B must be treated with plasmaderived or...
The most important and prevalent inherited bleeding disorders are hemophilia A and B, rare...
ACE910 is a recombinant humanized bispecific antibody that binds to activated factor IX and...